This section is not available in the published analysis.
Verona Pharma: Audience
Verona Pharma is a biotechnology company focused on developing innovative treatments for chronic respiratory diseases. Their primary product, Ohtuvayre™ (ensifentrine), is the first inhaled novel mechanism for the maintenance treatment of COPD in over 20 years.